RiverFront Investment Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.3M Buy
64,265
+19,409
+43% +$4.52M 0.22% 67
2026
Q1
$11M Buy
44,856
+22,415
+100% +$5.22M 0.17% 70
2025
Q4
$4.64M Buy
22,441
+3,242
+17% +$641K 0.08% 86
2025
Q3
$3.56M Buy
19,199
+4,278
+29% +$733K 0.06% 94
2025
Q2
$2.28M Buy
14,921
+4,355
+41% +$669K 0.04% 103
2025
Q1
$1.75M Buy
10,566
+4,286
+68% +$671K 0.04% 110
2024
Q4
$908K Buy
6,280
+541
+9% +$83.8K 0.02% 126
2024
Q3
$930K Buy
+5,739
New +$914K 0.02% 111

Other funds holding JNJ

RiverFront Investment Group's JNJ Position: Q2 2026 in Review

RiverFront Investment Group increased its Johnson & Johnson (JNJ) stake by 43% in Q2 2026, buying an estimated $4.52M and bringing the position to 64,265 shares worth $16.3M. The position accounts for 0.22% of the portfolio, ranked #67.

RiverFront Investment Group first reported a position in JNJ in Q3 2024 and has held it in 8 quarters since. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • RiverFront Investment Group held 64,265 shares of Johnson & Johnson worth $16.3M as of Q2 2026.
  • RiverFront Investment Group bought 19,409 Johnson & Johnson shares in Q2 2026, an estimated $4.52M.
  • Johnson & Johnson made up 0.22% of RiverFront Investment Group's portfolio in Q2 2026, its #67 holding.
  • RiverFront Investment Group first reported a position in Johnson & Johnson in Q3 2024 and has held it in 8 quarters since.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on RiverFront Investment Group's 13F filing for Q2 2026, filed 29 Jul 2026.